1(3H)-Isobenzofuranone,6,7-dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-,(3S)- cas no:128-62-1
Synonyms: 1(3H)-Isobenzofuranone,6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-,[S-(R*,S*)]-;Narcotine (7CI,8CI);(-)-Narcotine;(-)-a-Narcotine;Capval;Coscopin;L-a-Noscapine;Longactin;Longatin;Methoxyhydrastine;NSC 5366;Narcompren;Narcosine;Narcotin;Narcotussin;Nectadon;Nicolane;Nipaxon;Noscapin;Noscapine;Opian;Opianin;Opianine;Tusscapine;Vadebex;a-Narcotine;
Name1(3H)-Isobenzofuranone,6,7-dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-,(3S)-
CAS128-62-1
Synonyms1(3H)-Isobenzofuranone,6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-,[S-(R*,S*)]-;Narcotine (7CI,8CI);(-)-Narcotine;(-)-a-Narcotine;Capval;Coscopin;L-a-Noscapine;Longactin;Longatin;Methoxyhydrastine;NSC 5366;Narcompren;Narcosine;Narcotin;Narcotussin;Nectadon;Nicolane;Nipaxon;Noscapin;Noscapine;Opian;Opianin;Opianine;Tusscapine;Vadebex;a-Narcotine;
EINECS(EC#)204-899-2
Molecular FormulaC22H23NO7
Molecular Weight413.42
AppearanceCrystalline solid
alpha-200 º (C=1 IN CHLOROFORM)
Globally Harmonized System of Classification adn Labelling of Chemicals(GHS)
Hazardclass6.1(b)
Hazard Xn:Harmful;
Risk R22
Safety
Moderately toxic by ingestion and subcutaneous routes. Mutation data reported. An antitussive. When heated to decomposition it emits toxic fumes of NOx.
Safety Information of Narcotine (128-62-1):
Hazard Codes: Xn.gif)
Risk Statements: 22
22: Harmful if swallowed
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
dog |
LDLo |
intravenous |
73200ug/kg (73.2mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Oyo Yakuri. Pharmacometrics. Vol. 2, Pg. 323, 1968. |
mouse |
LD50 |
intraperitoneal |
960mg/kg (960mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 24, Pg. 2331, 1982. |
mouse |
LD50 |
intravenous |
83mg/kg (83mg/kg) |
|
Toxicology and Applied Pharmacology. Vol. 3, Pg. 96, 1961. |
mouse |
LD50 |
oral |
853mg/kg (853mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 24, Pg. 2331, 1982. |
mouse |
LD50 |
subcutaneous |
725mg/kg (725mg/kg) |
|
Russian Pharmacology and Toxicology Vol. 31, Pg. 338, 1968. |
rat |
LD50 |
oral |
1520mg/kg (1520mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 24, Pg. 2331, 1982. |